2005 Volume 25 Issue 6 Pages 815-820
The aim of this study was to evaluate IVR therapy for hemorrhage after surgery and rupture of hepatocellular carcinomas (HCCs). Of 14 patients with postoperative hemorrhage after pancreatoduodenectomy (PD) or other operations, 10 patients were treated with IVR, and 4 patients underwent emergency surgery. Of the IVR patients, hemostasis was successful in 4 (40%). Of the 6 patients in whom hemostasis could not be obtained with IVR, subsequent emergency surgical treatments were successful in 5. Of 18 patients with HCC rupture, bleeding was successfully controlled in 14 patients who underwent IVR. Four non-IVR patients died within 1 month. Of the 14 IVR patients, 4 had nonresectable HCCs treated with IVR, and survived 11.5± 2.4 months. The cumulative 5-year survival rate of the patients who had hepatectomy after IVR was 67.5% (n=10). IVR therapy for gastrointestinal or intraperitoneal hemorrhage has proved indispensable to abdominal surgeons, and we should have the flexibility to select IVR or surgical treatment for hemorrhage according to the situations of each individual patient and the hemorrhage.